Behind the Study: Novel TRKB Agonists Activate TRKB and Downstream ERK and AKT Signaling
November 1, 2022
Dr. Ya-Jen Chiu discusses a research paper she co-authored that was published by Aging (Aging-US), entitled, “Novel TRKB agonists activate TRKB and downstream ERK and AKT signaling to protect Aβ-GFP SH-SY5Y cells against Aβ toxicity.” continue reading »